SC 13G: CASI Pharmaceuticals, Inc.

AI Summary

SC 13G filing by CASI Pharmaceuticals, Inc..

Risk Assessment

Risk Level: low

FAQ

Key Financial Figures

• $0.0001 — of Issuer) Ordinary Shares, par value $0.0001 (Title of Class of Securities) G1933S

Filing Documents

• tm2417376d1_sc13g.htm (SC 13G) — 74KB
• 0001104659-24-073623.txt ( ) — 76KB

(A). NAME OF ISSUER

ITEM 1(A). NAME OF ISSUER CASI Pharmaceuticals, Inc. (the "Issuer")

(B). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE

ITEM 1(B). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES 1701-1702, China Central Office Tower 1 No. 81 Jianguo Road, Chaoyang District, Beijing, 100025 People's Republic of China.

(A). NAME OF PERSONS FILING

ITEM 2(A). NAME OF PERSONS FILING This Schedule is filed by Foresite Capital Fund VI, L.P., a Delaware limited partnership ("FCF VI"), Foresite Capital Management VI, LLC, a Delaware limited liability company ("FCM VI") and James Tananbaum. The foregoing entities and individuals are collectively referred to as the "Reporting Persons."

(B). ADDRESS OF PRINCIPAL OFFICE

ITEM 2(B). ADDRESS OF PRINCIPAL OFFICE The address for each of the Reporting Persons is: c/o Foresite Capital Management 900 Larkspur Landing Circle, Suite 150 Larkspur, CA 94939

(C). CITIZENSHIP

ITEM 2(C). CITIZENSHIP See Row 4 of cover page for each Reporting Person.

(D). TITLE OF CLASS OF SECURITIES

ITEM 2(D). TITLE OF CLASS OF SECURITIES Ordinary Shares, par value $0.0001

(E) CUSIP NUMBER

ITEM 2(E) CUSIP NUMBER G1933S101

If this

ITEM 3. If this is a: Not applicable. CUSIP # G1933S101 Page 6 of 10

OWNERSHIP

ITEM 4. OWNERSHIP The following information with respect to the ownership of the Ordinary Shares of the Issuer by the persons filing this Statement is provided as of June 10, 2024: (a) Amount beneficially owned : See Row 9 of cover page for each Reporting Person. (b) Percent of Class : See Row 11 of cover page for each Reporting Person. (c) Number of shares as to which such person has : (i) Sole power to vote or to direct the vote : See Row 5 of cover page for each Reporting Person. (ii) Shared power to vote or to direct the vote : See Row 6 of cover page for each Reporting Person. (iii) Sole power to dispose or to direct the disposition of : See Row 7 of cover page for each Reporting Person. (iv) Shared power to dispose or to direct the disposition of : See Row 8 of cover page for each Reporting Person.

OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS

ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS Not applicable.

OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON

ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON . Under certain circumstances set forth in the limited partnership agreement of FCF VI and the limited liability company agreement of FCM VI, the partners or members, as the case may be, of each of such entities may be deemed to have the right to receive dividends from, or the proceeds from the sale of, shares of the Issuer directly or indirectly owned by each such entity of which they are a partner or member.

IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED

ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY Not applicable.

IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP

ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP . Not applicable

NOTICE OF DISSOLUTION OF GROUP

ITEM 9. NOTICE OF DISSOLUTION OF GROUP . Not applicable CUSIP # G1933S101 Page 7 of 10

CERTIFICATION

ITEM 10. CERTIFICATION . By signing below, I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. CUSIP # G1933S101 Page 8 of 10

SIGNATURES

SIGNATURES After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: June 20, 2024 FORESITE CAPITAL FUND VI, L.P. By: FORESITE CAPITAL MANAGEMENT VI, LLC Its: General Partner By: /s/ James Tananbaum Name: James Tananbaum Title: Managing Member FORESITE CAPITAL MANAGEMENT VI, LLC By: /s/ James Tananbaum Name: James Tananbaum Title: Managing Member JAMES TANANBAUM By: /s/ James Tananbaum Name: James Tananbaum CUSIP # G1933S101 Page 9 of 10 EXHIBIT INDEX Found on Sequentially Exhibit Numbered Page Exhibit A: Agreement of Joint Filing 10 CUSIP # G1933S101 Page 10 of 10 exhibit A Agreement of Joint Filing The undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the Ordinary Shares of the Issuer shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13G. Date: June 20, 2024 FORESITE CAPITAL FUND VI, L.P. By: FORESITE CAPITAL MANAGEMENT VI, LLC Its: General Partner By: /s/ James Tananbaum Name: James Tananbaum Title: Managing Member FORESITE CAPITAL MANAGEMENT VI, LLC By: /s/ James Tananbaum Name: James Tananbaum Title: Managing Member JAMES TANANBAUM By: /s/ James Tananbaum Name: James Tananbaum

View Full Filing

View this SC 13G filing on SEC EDGAR